SCHEMBL7528356

SCHEMBL7528356

COc1ccc(C(=O)c2cn(CC(=O)O)c(=O)nc2N)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 1/20 0.45
CNR2 P34972 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 1/20 0.43
LMNA P02545 3/20 0.43
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
MAPT P10636 3/20 0.42
PTGS2 P35354 1/20 0.42
GAA P10253 1/20 0.42
HTT P42858 1/20 0.42
CCNA2 P20248 1/20 0.42
CDK2 P24941 1/20 0.42
MAPKAPK2 P49137 1/20 0.41
ALDH1A1 P00352 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CDK5 Q00535 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7639805 0.85 KMT2A (0.55) MAPK14CNR2LMNATP53MAPT
SCHEMBL7635960 0.83 SRD5A2 (0.41) NPC1RAB9ASMN1; SMN2TDP1ALDH1A1
SCHEMBL7874474 0.73 P2RX7 (0.37) NPC1RAB9ATP53SMN1; SMN2MAPT
SCHEMBL8769047 0.70 ALDH1A1 (0.44) LMNAMAPTGAAALDH1A1KMT2A
SCHEMBL10838644 0.70 NPC1 (0.41) CNR2NPC1RAB9ALMNATP53
SCHEMBL7528362 0.69 ADORA3 (0.51) NPC1RAB9ATP53SMN1; SMN2MAPT
SCHEMBL17868339 0.69 NPC1 (0.55) MAPK14NPC1RAB9ALMNAMAPT
SCHEMBL3840933 0.69 MAPT (0.55) MAPK14NPC1RAB9ALMNAMAPT
SCHEMBL6886945 0.67 KMT2A (0.50) CNR2NPC1RAB9AALDH1A1KMT2A
SCHEMBL6880479 0.66 KMT2A (0.52) CNR2NPC1RAB9ASMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6465650-B1 INTERMEDIATE STEPS IN PREPARING PEPTIDE NUCLEIC ACIDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2002-10-15 US disclosed
EP-0761681-B1 Process for the preparation of substituted derivatives of N-ethylglycine HOECHST AG (DE) 2002-03-13 EP disclosed
EP-0761681-A2 Process for the preparation of substituted derivatives of N-ethylglycine HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-12 EP disclosed